BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 5439720)

  • 21. [Hemagglutinin of rubella virus: its characteristics and uses in epidemiology and clinical medicine].
    Grasso A; Gagnoni G; Cantagalli P; Dianzani F; Piazzi SE
    G Mal Infett Parassit; 1969 Jul; 21(7):603-15. PubMed ID: 5364953
    [No Abstract]   [Full Text] [Related]  

  • 22. [Rubella antibodies in the female population. Studies in Bavaria (1969)].
    Eife G; Vogt D
    Munch Med Wochenschr; 1970 Apr; 112(5):709-11. PubMed ID: 5538043
    [No Abstract]   [Full Text] [Related]  

  • 23. Epidemiological survey of rubella immunity in Iran.
    Saidi S
    Bull World Health Organ; 1972; 46(4):563-5. PubMed ID: 4538202
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sero-epidemiological studies of the anti-rubella immunological status of a sample of the female population].
    Pagliarella P; La Rosa F; Pannelli F; Orpianesi C; Cresci A; Vitali C
    G Batteriol Virol Immunol; 1980; 73(7-12):234-41. PubMed ID: 7308615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of anti-rubella immunity in the Socialist Republic of Rumania with the hemagglutination inhibition (HAI) test].
    Măgureanu E; Grobnicu M; Muşetescu M; Dumitrescu S; Popescu A
    Microbiol Parazitol Epidemiol (Bucur); 1969; 14(3):215-20. PubMed ID: 5344217
    [No Abstract]   [Full Text] [Related]  

  • 26. Rubella antibodies in Uganda.
    Bracken PM; Stanfield JP
    East Afr Med J; 1971 Apr; 48(4):176-81. PubMed ID: 5129677
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hemagglutination inhibiting antibodies to measles, rubella, and parotitis. Study of their prevalence in a community of the Mexican plateau].
    Golubjatnikov R; Leppla L; Filloy L
    Salud Publica Mex; 1970; 12(5):603-9. PubMed ID: 5509277
    [No Abstract]   [Full Text] [Related]  

  • 28. The seroepidemiology of rubella in Kuala Lumpur, West Malaysia.
    Lam SK
    Bull World Health Organ; 1972; 47(1):127-9. PubMed ID: 4538899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A study of hemagglutination-inhibiting rubella antibodies].
    Grobnico M; Măgureanu E; Solomon E; Muşetesco M
    Arch Roum Pathol Exp Microbiol; 1968 Jun; 27(2):323-8. PubMed ID: 5707385
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rubella epidemiology in rural Upper Volta].
    Monjour L; Druilhe P; Huraux JM; Palminteri R; Froment A; Kyelem JM; Alfred C; Laplace JL; Gentilini M
    Acta Trop; 1982 Sep; 39(3):247-52. PubMed ID: 6128893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection and titration of hemagglutination-inhibiting antibodies against measles virus in a sample of the population of Rome].
    Balestrieri A; Russo V
    Arch Ital Sci Med Trop Parassitol; 1967; 48(7):187-98. PubMed ID: 5609910
    [No Abstract]   [Full Text] [Related]  

  • 32. [Epidemiological behavior of rubella in the province of Córdoba, Argentina].
    Marquez A; Zapata MT
    Bol Oficina Sanit Panam; 1984 Jul; 97(1):14-25. PubMed ID: 6236826
    [No Abstract]   [Full Text] [Related]  

  • 33. [Seroepidemiology of rubella in Tunisia].
    Nabli B
    Bull World Health Organ; 1970; 42(6):891-6. PubMed ID: 5312251
    [No Abstract]   [Full Text] [Related]  

  • 34. Serology of rubella. Virus neutralization, immunofluorescence in BHK21 cells, and hemagglutination inhibition.
    Deibel R; Cohen SM; Ducharme CP
    N Y State J Med; 1968 Jun; 68(11):1355-62. PubMed ID: 4870797
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rubella. Serological survey in Pelotas, Rio Grande do Sul, Brazil].
    de Mattos IG; de Moraes Andrade C; Vasconcelos Mamfrim AJ; Ferreira ME
    Rev Inst Med Trop Sao Paulo; 1978; 20(2):99-101. PubMed ID: 675034
    [No Abstract]   [Full Text] [Related]  

  • 36. Incidence of rubella hemagglutination-inhibiting (HAI) antibody in female subjects in Helsinki.
    Vesikari T; Vaheri A; Kauppinen MA
    Ann Med Exp Biol Fenn; 1968; 46(1):109-12. PubMed ID: 5727655
    [No Abstract]   [Full Text] [Related]  

  • 37. [Distribution of anti-ECHO hemagglutination-inhibiting antibodies in the population of the city of Bucharest].
    Solomon I; Busuioc C; Scheau A; Ionescu V; Stoicescu A
    Stud Cercet Inframicrobiol; 1968; 19(6):429-35. PubMed ID: 5731175
    [No Abstract]   [Full Text] [Related]  

  • 38. Epidemiology of rubella on Taiwan.
    Gale JL; Detels R; Kim KS; Beasley RP; Grayston JT
    Am J Dis Child; 1969 Jul; 118(1):143-5. PubMed ID: 5790242
    [No Abstract]   [Full Text] [Related]  

  • 39. Rubella antibody studies in the inhabitants of Montreal. Incidence of hemagglutination-inhibiting, complement-fixing and neutralizing antibodies.
    Chagnon A; Davignon L; Pavilanis V
    Can J Public Health; 1969 Oct; 60(10):395-401. PubMed ID: 5345621
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on live rubella vaccine. II. Field trials with two experimental vaccine strains.
    Minekawa Y; Suzuki N; Takahashi M; Okuno Y
    Biken J; 1968 Dec; 11(4):243-50. PubMed ID: 5721530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.